Trials / Completed
CompletedNCT03811678
The Tolerability and Pharmacokinetics Study of Kangdaprevir Sodium Tablet in Healthy Adult Subjects
A Phase I, Single-center, Randomized，Double-blind, Placebo-controlled, Single & Multiple Ascending Dose Study to Assess the Tolerability and Pharmacokinetics of Kangdaprevir Sodium Tablet in Healthy Adult Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Sunshine Lake Pharma Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The Tolerability and Pharmacokinetics Study of Kangdaprevir Sodium Tablet in Healthy Adult Subjects.
Detailed description
A Phase I, Single Center, Randomized, Double-blind, Placebo-controlled, Single \& Multiple Ascending Dose Study to Access the Tolerability and Pharmacokinetics of Kangdaprevir Sodium Tablet in Healthy Adult Subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Kangdaprevir Sodium Tablet | Tablet，administered orally once daily |
| DRUG | placebo | Tablet，administered orally once daily |
Timeline
- Start date
- 2018-01-11
- Primary completion
- 2018-05-29
- Completion
- 2018-05-29
- First posted
- 2019-01-22
- Last updated
- 2020-03-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03811678. Inclusion in this directory is not an endorsement.